Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hui Shi, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2022-04-01
סדרה:Frontiers in Pharmacology
נושאים:
treatment-resistant
ziprasidone
sertraline
efficacy
schizophrenia
acute exacerbation
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fphar.2022.863588/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים